 In addition to encouraging preclinical data from the COVID-19 antibody cocktail announced today, Immunome Inc NASDAQ: IMNM has entered into a private placement agreement of approximately 27 million with the sale of 1 million units at 27 per unit. The offer price is at a 9 discount to Fridays closing price of 29.55. 